<ul><li>Prelim 47.0</li><li>Prior was 49.0</li></ul><p>The ISM manufacturing survey is coming up at the top of the hour.</p> This article was written by
<p>Company to provide update on its emerging pipeline of high-value immunology programs WATERTOWN, Mass., Dec. 13, 2023 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a c
Leave a Comment